They found that a full Nr5a2 dose is required to restore pancreatic homeostasis upon damage and to suppress the KRasG12V-driven mouse pancreatic intraepithelial neoplasia progression, indicating that Nr5a2 is a novel pancreatic tumor suppressor [31]. Here, NR5A2 is linked to pancreatic neoplasm.